Friday, 19 October 2012

Rapid Screening Test For Glaucoma


Worldwide glaucoma is a leading cause of irreversible adult blindness. There is no cure for glaucoma but early diagnosis can allow disease progression to be stopped. Current readily-available optometry tests have a high false positive rate and do not reliably detect early-stage disease. A new rapid and non-invasive test has been developed for detecting early stage glaucoma by researchers at the University of Aberdeen. The test is PC-based and uses the way that humans perceive moving objects to detect abnormalities in visual processing associated with retinal neuropathies such as glaucoma. Performance on the test relates to the degree of neural damage to the retina.
Key Benefits:
  • Specificity and selectivity of test comparable to industry gold standard (Humphrey VFA)
  • Indicates severity of disease stage
  • Potential to detect glaucoma prior to visual field defect
Applications:
  • Rapid and simple test for glaucoma
  • May be applicable to other retinal neuropathies such as optic neuritis, diabetes and MS
  • Cost-effective mass screening test
  • Addition to other PC-based screening tools

New Algorithm Improves Performance In Wireless Communication Systems


Innovation in Mobile Communications

The Challenge
The use of multiple antenna at both receiver and transmitter (multiple input – multiple output - “MIMO”) has the potential to dramatically increase the rate of data transmission.  Adoption of this technology for use in wireless communications requires improved reliability of data transmission, while avoiding inter-channel interference, and without increasing the use of power or bandwidth.

Technology
This new simple algorithm (‘Trellis Coded Spatial Modulation’) developed by the University of Edinburgh requires only one active transmit antenna to achieve an equivalent rate of data transmission to multiple parallel transmissions.  This unique approach reduces use of both power and bandwidth – limited resources in wireless networks.  In addition, by partitioning the flow of data from the transmit antenna into subsets, the distance between the antennae can be maximised. This reduces channel interference when the antennae are too close together, which leads to picking up incorrect data. This is termed as spatial correlation and affects the overall quality and strength of the transmitted signal.

Exemplification Data
Initial computer simulation and now real-time video streaming application has been implemented successfully, which clearly demonstrates that this technology improves data transmission, power efficiency and computational complexity compared to current techniques making it a practical solution. The deliverability of this innovation has been demonstrated through the construction of a laboratory demonstrator.
Key Benefits:
  • Power efficient - same performance on less power giving a longer device battery life
  • Lower computational complexity enabling use of data hungry devices
  • Reduced time to transmit data - quicker download times
  • Ready to adopt - applicable for use with current mobile phones
Applications:
  • Mobile handheld devices
  • Sensor networks
  • Multihop communications

Temperature Control System For Long-Term Stabilisation Of Tissue Slices


Innovation in bioscience instrumentation
The Edinburgh Temperature Controller System (ETC) provides a unique solution for monitoring and controlling a full electrophysiology rig and provides the capability to run acute-slice experiments overnight.
In a brain slice chamber, the conventional heater can cause droplets of condensation from the fluid filled chamber to form on the cooler electrodes and consequently limit the time available to collect brain slice recording.
Rather than controlling the heating of the slice chamber, the proprietary temperature software controller maintains the temperature of everything within the insulated rig. The temperature of the oxygenated air, the brain slice, the electrodes and the remaining rig equalise providing a stable environment for long-term recordings.
For example, the temperature can be maintained at a constant 32°C and extend the length of slice viability to times that allow investigations of long-term changes in synaptic connectivity.
The Edinburgh Temperature Controller software developed by the University of Edinburgh is available and works with off-the-shelf controller instrumentation.
An ETC System can run multiple rigs using additional channels, up to a maximum of 8 rigs (employing 1 ETC System with 7 additional channels).  A minimum of one system per room is recommended.
Key Benefits:
  • Accurate control of temperature (+/- 0.1°C)
  • Monitor and control of temperature of electrophysiology rig in excess of 12 hours
  • Eliminates the formation of water droplets on recording electrodes
  • One system can control several rigs leading to savings over other temperature controllers
  • Works with off-the-shelf controller instrumentation
Applications:
  • Synaptic connectivity in brain slices
  • Intestinal tissue samples
  • Pericardial heart tissue samples

FITVOICE


About Opportunity:

Increasing evidence shows that people who rely on their voices for work are at risk of developing voice problems. Time off work due to voice stress and strain costs the UK economy £200 million each year and has a detrimental impact on the education profession and businesses which rely on a large percentage of their workforce using the voices consistently throughout the working day.

This development by Queen Margaret University has implications for a third of the workforce who rely on their voices for their jobs, for example teachers and contact centre workers.

Dr Felix Schaeffler and Dr Janet Beck have devised a mobile phone ‘app’ that can be used on the Apple iPhone and iPod Touch allowing workers to record voice samples and questionnaire data and submit them for analysis by experts. The experts can then provide feedback and advice on what can be done to limit future damage.

Key Benefits:


  • A quick, easy and cost-effective way of identifying voice problems before they become serious enough to require medical treatment.
  • The development of tailored advice which will allow people to protect their voice.
  • Service can potentially be provided to a large number of people.

Applications:


  • Education – to monitor voice quality in teaching.
  • Contact Centres – to maximise the efficiency of voice in a sales or commercial environment.

Access Vessel For Offshore Structures


Rough sea conditions make it difficult and dangerous to access offshore structures, such as wind turbines, restricting access to around 50% of the year. It is estimated that up to 165 days a year are lost due to the weather limitations of existing transfer methods. This can result in lengthy periods of inaccessibility, incurring production losses. This issue has spurred the the University of Strathclyde to develop the Offshore Access Vessel (OAV), which can be used in a number of offshore applications.

The OAV's revolutionary design enables both fast transit and stable transfer, utilising two configurations and a unique transformation ability to change from a fast, efficient catamaran to a stable semi-submersible on site. The semi-submersible configuration reduces vessel movement in high sea conditions so that crew can easily transfer from the deck onto the offshore structure more safely.

The vessel’s hulls are connected to the deck by four legs and can be submerged under the surface of the water. disconnects the vessel movement from the surface motion of the sea, minimising deck movement. The deck is jacked upwards, clear of the water surface, so it is not adversely effected by the dangers associated with waves slamming and flooding. The OAV is floating at all times during normal operation and does not make contact with the seabed for support. The OAV incorporates novel technology to ensure stability at all times.

The roll, pitch and heave periods are de-coupled from the normal frequency of waves at the intended  operational site,  when the vessel is in the semi-submersible configuration. The OAV has sufficient buoyancy in the deck that it will continue to float when all ballast water is taken on, even if the deck is not jacked up.

This unique system design has been commended by the Carbon Trust Offshore Accelerator.

Key Benefits:


  • Increased transfer safety.
  • Increased access availability.
  • Offers fast transit speed.
  • Controllable stability characteristics for different sea conditions.

Applications:


  • Offshore wind.
  • Oil & gas.
  • Offshore maintenance.

Docking Gangway For Offshore Structures


The SolidSeaTransfer access system is an innovative gangway developed by the University of Strathclyde that reduces the risks of personnel and equipment transfers by creating a flexible bridge between a service vessel and an offshore structure, allowing crew and equipment to transfer safely in rough sea conditions.
Rough sea conditions make it difficult and dangerous to access offshore structures by sea. In the example of the offshore wind industry, it is estimated that up to 165 days a year are lost due to the weather limitations of the existing transfer method. This can result in lengthy periods of inaccessibility, incurring production losses.
The SolidSeaTransfer access system allows a transfer vessel to move with the waves during transfers and can be retrofitted to existing vessels. The system can provide access in wave heights of up to 3m significant wave height (SWH), rather than 1.5m (SWH) which is estimated to be the current threshold for offshore turbine transfers.
The design incorporates a unique structure connector which creates a secure point of transfer and adjusts to wave height. The flexible, pivoted gangway bridges the gap between the vessel and the offshore structure, increasing the safety and operational range of transfers. 
Transfer is made from the vessel’s midpoint, where vessel motion is at a minimum. There are railings to support transferees at all times, providing a secure connection for harnesses and lanyards.
Key Benefits:
  • Increased transfer safety.
  • Usable in rough seas.
  • Unique structure connector.
  • Passive motion compensation.
Applications:
  • Offshore wind.
  • Oil & gas.
  • Offshore maintenance.
  • Ship-to-ship transfer operations.

Combination Treatment For MRSA Nasal Carriage And MRSA-Infected Wounds


Methicillin-resistant Staphylococcus aureus (MRSA) is the most common drug-resistant pathogen that can infect skin, soft tissues, major organs and the blood.  MRSA infections are often resistant to conventional antibiotics compromising effective treatment meaning new and reliable therapies are urgently required.
Patients colonised by S. aureus or MRSA are more likely to b einfected and so patients, identified as carriers prior to surgery, are treated to eradicate these pathogens.  However, resistance to mupirocin, the antibiotic of choice for reducing such carriage, is increasing and treatment failure is more often encountered.  Hence a particularly attractive opportunity exists to provide an alternative de-colonisation cream.
The new treatment developed by the University of St Andrews is a combination of a peptide (ranalexin) with a bacteria cell wall-digesting protein (lysostaphin), which specifically targets and kills Staphylococcus aureus, including MRSA.  The combination is synergistic;these components are more active together compared to the components on their own against lysostaphin-resistant S. aureus and also vancomycin-intermediate resistant (VISA) isolates.  Furthermore, unlike conventional antibiotics the combination kills non-multyplying bacteria.
The combination is highly efficacious in vivo in an animal model, ex vivo on the surface of human skin and when dried on the surface of catheter tubing.  In animals, we demonstrated that when the combination is impregnated into dressings and applied to MRSA-infected wounds for 5 days it reduces MRSA in these lesions by >99% compared to untreated controls and wounds treated with the individual components.  The combination was more effective compared to vancomycin-treated animals.  The combination can be used topically to treat MRSA-infected wounds.
Similarly, the combination demonstrated enhanced efficacy for reducing MRSA on living human skin compared to the individual components alone.  The combination is an effective de-colonisation agent specifically capable of reducing MRSA carriage without adversely affecting the skin's normal protective microflora.
Key Benefits:
  • Combination antibacterial treatments are less likely to induce bacterial resistance
Applications:
  • Topical agent to eradicate MRSA nasal carriage in pre-operative patients as an alternative to mupirocin
  • Incorparated into dressings or applied topically to treat MRSA-infected wounds
  • Anti-Staphylococcal coating for indwelling medical devices, such as catheters
  • Treatment to specifically remove Staphylococcus aureus and MRSA from skin or other surfaces

Subtype Selective Phosphodiesterase 4 Inhibitors For The Treatment Of Chronic Obstructive Pulmonary Disease


Chronic Obstructive Pulmonary Disease (COPD) is a severely disabling lung illness and is currently the fourth most common cause of death worldwide. Available therapeutics mostly target symptom relief, leaving a strong need for new, disease-targeted medications.
Using a novel screening approach, researchers at Strathclyde University have identified subtype selective Phosphodiesterase 4 (PDE4) inhibitors. These are being optimised with the aim of delivering 'best in class' therapeutics to reduce the destructive lung inflammation that characterises COPD.
Key Benefits:
  • Predicted superior efficacy and safety over current therapies.
  • Potential to slow or halt disease progression.
  • Improved tolerability compared to 'global' PDE4 inhibitors.
Applications:
  • COPD has a high average incidence rate of 8.1% in the general population of the seven major pharmaceutical markets, with the global COPD market projected to reach $14bn per year by 2014 and continue to expand through a combination of increasing incidence and improved screening and diagnosis.

CMOS-Compatible Single Photon Avalanche Diode With Improved Near Infra Red Sensitivity


The Challenge
The capability to detect down to a single photon level makes SPADs attractive for applications where photon timing is desirable or high speed, low light imaging required. For SPADs to be commercially attractive, it is important that they are CMOS-compatible. However, the utility of such devices is currently limited by an inherent drop in sensitivity at red light wavelengths. NIR light is attractive for ranging systems because of its low energy and invisibility to the naked eye. Single photon sensitivity is also important in biological analysis where blue light, a prerequisite with existing SPADs, has the disadvantage of damaging cells, unlike NIR.
Technology
Through its unique design, Edinburgh Universities new construction facilitates vastly improved photon detection in the red and NIR spectrum. The device is 9x more sensitive than existing technology, providing a high sensitivity solution, especially where longer wavelength light is optimal or high energy light not tolerated. The improvement of detection efficiency means lower power illumination sources can be used, the active range improved and systems are more likely to be safe to the naked eye. The design is compatible with standard CMOS, highly cost effective and can be readily integrated into electronic micro systems.
Exemplification Data
A prototype device has been fabricated that demonstrates the improved spectral sensitivity of the novel device. Further improvement (Mk. 2) has been experimentally demonstrated with additional enhancement indicated from calibrated simulation results.
Key Benefits:
  • Enables use in new applications such as high efficiency range finding and biological applications
  • Device is highly cost-effective and scalable
  • Permits use of lower power and eye-safe illumination sources
  • Next generation back-side illumination (BSI) approaches for high fill factor and optical efficiency
Applications:
  • Life science analysis equipment
  • 3D Imaging
  • Range finder
  • Positron emission tomography (PET) detector

Bilosomes: Novel Vehicles For Oral Delivery Of Drugs

Oral administration remains the favoured method of drug delivery by patients. For a drug to be successfully absorbed by the body it requires the active molecule to transit through the stomach and then to be transferred across the intestinal wall to the bloodstream. For a majority of vaccines and biologic therapeutics this is not an option due to a 1% uptake of the dose given. Approximately 1/3 of small molecule drugs also face oral absorption challenges (www.nature.com/nrd/journal/v5/n12/full/nrd2199.html) many of these are focussed on CNS targets.

Scientists at Strathclyde University have developed Bilosomes, bile salt stabilised vesicles that act as an envelope to protect their contents from the harsh environment of the gut enabling oral administration. The system was well tolerated in in vivo toxicology studies.